1887

Abstract

Summary

Immune-stimulating complexes (iscoms), which have recently been shown to be highly effective for the antigenic presentation of membrane proteins of viruses, were prepared with affinity-purified fusion (F) protein of measles virus (MV), using an adaptation of the standard method for iscom preparation. Immunization of monkeys with the F iscom preparation induced biologically active anti-F protein antibodies as was shown in haemolysis inhibition and cell-cell fusion inhibition tests. A whole MV iscom preparation, which also contained the haemagglutinin protein, induced not only haemolysis-inhibiting antibodies, but, in contrast to the F iscom preparation, also haemagglutination-inhibiting and virus-neutralizing antibodies. In addition the F iscom preparation was shown to activate measles virus-specific T cells in mice. This was demonstrated by the generation of an MV-specific delayed type hypersensitivity response in F iscom-immunized animals and by the isolation of T cell clones specific for MV F protein with the T helper phenotype. Vaccination of mice with MV iscom or F iscom protected them from MV-induced fatal encephalopathy. The data concerning the immunogenicity of MV proteins presented in iscoms are discussed in relation to their potential for the development of an inactivated measles vaccine.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-69-3-549
1988-03-01
2022-01-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/69/3/JV0690030549.html?itemId=/content/journal/jgv/10.1099/0022-1317-69-3-549&mimeType=html&fmt=ahah

References

  1. BRADFORD M.M. 1976; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72:248–254
    [Google Scholar]
  2. COMMITTEE ON ISSUES FOR NEW VACCINE DEVELOPMENT 1985 New Vaccine Development Establishing Priorities 1385–396 Division of Health Promotion and Disease Prevention, Institute of Medicine, National Academy of Sciences, U.S.A. Washington, D.C.: National Academy Press;
    [Google Scholar]
  3. DE VRIES P., VAN BINNENDIJK R.S., VAN DER MAREL P., BEUVERY E.C., VAN WEZEL A.L., VOORMA H.O., UYTDEHAAG F.G.C.M., OSTERHAUS A.D.M.E. 1987; Inhibition of measles virus induced cell-cell fusion with a monoclonal antibody directed against the haemagglutinin. Viral Immunology 1:25–34
    [Google Scholar]
  4. FLEBBE L.M., BRALEY-MULLEN H. 1986; Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens. Cellular Immunology 99:119–127
    [Google Scholar]
  5. FULGINITI V.A., ELLER J.J., DOWNIE A.W., KEMPE C.H. 1967; Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. Journal of the American Medical Association 202:1075–1080
    [Google Scholar]
  6. HARDWICK J.M., BUSSELL R.H. 1978; Glycoproteins of measles virus under reducing and non-reducing conditions. Journal of Virology 25:687–692
    [Google Scholar]
  7. HOWARD C.R., SUNDQUIST B., ALLAN J., BROWN S.E., CHEN S-H., MOREIN B. 1987; Preparation and properties of immune-stimulating complexes containing hepatitis B virus surface antigen. Journal of General Virology 68:2281–2289
    [Google Scholar]
  8. KURNICK J.T., OSTBERG L., STEGAGNO M., KIMURA A.K., ÖRN A., SJÖBERG O. 1979; A rapid method for the separation of functional lymphoid cell populations of human and animal origin on PVP-silica (Percoll) density gradients. Scandinavian Journal of Immunology 10:563–573
    [Google Scholar]
  9. LAEMMLI U.K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
  10. LIEBERT U.G., TER MEULEN V. 1987; Virological aspects of measles virus-induced encephalomyelitis in Lewis and BN rats. Journal of General Virology 68:1715–1722
    [Google Scholar]
  11. MERZ D.C, SCHEID A., CHOPPIN P.W. 1980; Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. Journal of Experimental Medicine 151:275–288
    [Google Scholar]
  12. MOREIN B., SIMONS K. 1985; Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes. Vaccine 3:83–93
    [Google Scholar]
  13. MOREIN B., SUNDQUIST B., HOGLUND S., DALSGAARD K., OSTERHAUS A. 1984; Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature, London 308:457–459
    [Google Scholar]
  14. NORRBY E., GOLLMAR Y. 1972; Appearance and persistence of antibodies against different virus components after regular measles infections. Infection and Immunity 6:240–247
    [Google Scholar]
  15. NORRBY E., GOLLMAR Y. 1975; Identification of measles virus-specific hemolysis-inhibiting antibodies separate from hemagglutination-inhibiting antibodies. Infection and Immunity 11:231–239
    [Google Scholar]
  16. NORRBY E., ENDERS-RUCKLE G., TER MEULEN V. 1975; Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. Journal of Infectious Diseases 132:262–269
    [Google Scholar]
  17. NORRBY E., UTTER G., ÖRVELL C., APPEL M. 1986; Protection against canine distemper virus in dogs after immunization with isolated fusion protein. Journal of Virology 58:536–541
    [Google Scholar]
  18. ÖRVELL C. 1978; Immunological properties of purified mumps virus glycoproteins. Journal of General Virology 41:517–526
    [Google Scholar]
  19. OSTERHAUS A.D.M.E., VAN WEZEL A.L., VAN STEENIS G., DROST G.A., HAZENDONK A.G. 1981; Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains. Intervirology 16:218–224
    [Google Scholar]
  20. OSTERHAUS A.D.M.E., WEYER K., UYTDEHAAG F., JARRETT D., SUNDQUIST B., MOREIN B. 1985; Induction of protective immune response in cats by vaccination with feline leukemia virus iscoms. Journal of Immunology 135:591–596
    [Google Scholar]
  21. REZELMAN G., GOLDBACH R., VAN KAMMEN A. 1980; Expression of bottom component RNA of cowpea mosaic virus in cowpea protoplasts. Journal of Virology 36:366–373
    [Google Scholar]
  22. SCHEID A., CHOPPIN P.W. 1974; Identification of the biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57:475–490
    [Google Scholar]
  23. SCHEID A., CHOPPIN P.W. 1977; Two disulfide-linked chains constitute the active F protein of paramyxoviruses. Virology 80:54–66
    [Google Scholar]
  24. SCHEID A., CALIGUIRI L.A., COMPANS R.W., CHOPPIN P.W. 1972; Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology 50:640–652
    [Google Scholar]
  25. SHESHBERADARAN H., CHEN S.N., NORRBY E. 1983; Monoclonal antibodies against five structural components of measles virus. 1. Characterization of antigenic determinants on nine strains of measles virus. Virology 128:341–353
    [Google Scholar]
  26. SMITH R.H., ZIOLA B. 1984; Induction of delayed-type hypersensitivity to measles virus in mice. Cellular Immunology 89:20–29
    [Google Scholar]
  27. SUNDQUIST B., DALSGAARD K., MOREIN B. 1983; Assay of detergents by rocket electrophoresis in agarose gels containing red blood cells: rocket haemolysis. Biochemical and Biophysical Research Communications 114:669–704
    [Google Scholar]
  28. VAN WEZEL A.L., VAN STEENIS G., HANNIK C.H., COHEN H. 1978a; New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines. Developments in Biological Standardization 41:159–168
    [Google Scholar]
  29. VAN WEZEL A.L., VAN HERWAARDEN J.A.M., VAN DE HEUVEL-DE RIJK E.W. 1978b; Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines. Developments in Biological Standardization 42:65–69
    [Google Scholar]
  30. VARSANYI T.M., UTTER G., NORRBY E. 1984; Purification, morphology and antigenic characterization of measles virus envelope components. Journal of General Virology 65:355–366
    [Google Scholar]
  31. WAHREN B., NORDLUND S., AKESSON A., SUNDQVIST V.-A., MOREIN B. 1987; Monocyte and iscom enhancement of cell-mediated response to cytomegalovirus. Medical Microbiology and Immunology 176:13
    [Google Scholar]
  32. WILDE D.B., MARRACK P., KAPPLER J.W., DIALYNAS D.P., FITCH F.W. 1983; Evidence implicating L3T4 in class II MHC antigen reactivity: monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. Journal of Immunology 131:2178–2183
    [Google Scholar]
  33. WILSON B.M., NAKANE P.K. 1978 Recent developments in the periodate method of conjugating horseradish peroxidase (HRPO) to antibodies. Immunofluorescence and Related Staining Techniques215–222 Edited by Knapp W., Holubat K., Wick G. Amsterdam: Elsevier/North-Holland;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-69-3-549
Loading
/content/journal/jgv/10.1099/0022-1317-69-3-549
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error